Skip to main content

Table 3 Baseline biomarker concentrations and MBDA scores for patients in LDAS and remission at baseline

From: A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis

Baseline Biomarkers

LDAS (n = 40)

DAS28-ESR remission (n = 96)

DAS28-CRP remission (n = 74)

CDAI remission (n = 63)

SDAI remission (n = 59)

ACR/EULAR Boolean remission (n = 37)

EGF (pg/ml)

245 (160, 331)

254 (177, 368)

249 (160, 366)

248 (158, 359)

243 (157, 362)

249 (180, 373)

IL-6 (pg/ml)

13.65 (9.89, 24.35)

7.14 (5.56, 13.21)****

8.09 (5.67, 12.62)****

7.89 (5.58, 13.21)****

6.97 (5.41, 11.79)****

6.29 (4.41, 9.33)****

Leptin (ng/ml)

25 (6.3, 38)

8 (4, 17)*

8 (4, 16) *

7.00 (3.54, 14.10)*

6.33 (3.50,13.87)***

6.33 (3.50, 11.74)**

MMP-1 (ng/ml)

6.62 (4.41, 10.48)

6.80 (4.93, 9.49)

7.30 (5.07, 10.63)

7.52 (5.13, 10.78)

7.57 (5.19, 10.93)

7.47 (5.25, 1.09)

MMP-3 (ng/ml)

26 (17, 40)

26 (20, 38)

26 (17, 35)

26 (17, 37)

27 (17, 35)

27 (17, 40)

Resistin (ng/ml)

8.72 (6.40, 12.01)

7.04 (5.78, 8.72)**

7.11 (5.84, 9.54)*

7.37 (6.20, 9.69)

7.32 (6.04, 9.85)

7.92 (6.04, 9.54)

SAA (μl/ml)

2.82 (1.63, 6.17)

1.32 (0.69, 2.49)***

1.22 (0.65, 2.13)****

1.52 (0.65, 2.13)***

1.20 (6.43, 2.06)****

1.20 (0.65, 2.03)****

TNFR1 (ng/ml)

1.76 (1.37, 2.16)

1.50 (1.32, 1.92)*

1.51 (1.35, 1.99)

1.52 (1.33, 2.01)

1.51 (1.31, 1.99)

1.64 (1.34, 1.99)

VCAM1 (ng/ml)

587 (469, 732)

518 (433, 587)**

519 (440, 588)*

520 (425, 609)*

521 (430, 621)*

531 (457, 621)

VEGF (pg/ml)

294 (211, 365)

240 (166, 374)

246 (173, 408)

258 (174, 407)

247 (173, 407)

275 (176, 407)

YKL40 (ng/ml)

65 (42, 97)

51 (34, 70)*

56 (36, 92)*

53 (35, 102)

52 (34, 98)

56 (35, 92)

CRP (mg/ml)

6.41 (3.23, 14.10)

1.49 (0.61, 2.83)****

1.57 (0.61, 2.70)****

1.40 (0.78, 2.63)****

1.40 (0.56, 2.49)****

1.40 (0.44, 2.49)****

MBDA score (1–100)

39 (31, 50)

26 (16, 37)****

26 (16, 35)****

24 (16, 35)****

22 (16, 33)****

20 (15, 32)****

  1. Comparison of the low disease activity state (LDAS, defined as not fulfilling any clinical remission criteria) group to the DAS28-ESR, DAS28CRP, CDAI, SDAI and Boolean remission groups at baseline. LDAS was defined as patients who were not in remission by any definition at baseline
  2. Values are median (IQR). Levels of significance determined by Mann Whitney test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001